COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to tame deadly blood clots in sepsis patients
Disease control Recruiting nowThis study tests a new medicine, BAY 3389934, in people with sepsis who develop a dangerous blood clotting problem. The goal is to find a safe dose and see how the drug affects the body. About 36 adults in the ICU will take part, and the study lasts around 28 days.
Matched conditions: COAGULOPATHY
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
New Quick-Acting powder could save lives in severe trauma bleeding
Disease control Recruiting nowThis study tests whether a fast-acting powder form of fibrinogen (a protein that helps blood clot) works better than the standard frozen blood product for severe trauma patients with major bleeding. About 850 adults from Australia and New Zealand who need blood transfusions and h…
Matched conditions: COAGULOPATHY
Phase: PHASE3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New blood test for kids: will it measure up?
Knowledge-focused Recruiting nowThis study looks at how well a new device called TEG 6s measures blood clotting in children. About 125 kids under 18 having planned surgery will give a small blood sample. The goal is to find normal values for healthy children and compare them to published ranges. No treatment is…
Matched conditions: COAGULOPATHY
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC